Blood Biomarkers of Ischemic Stroke

Glen C. Jickling, Frank R Sharp

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysiology of ischemic stroke, including ischemia of CNS tissue, acute thrombosis and inflammatory response. These biomarkers are summarized by their intended clinical application in ischemic stroke including diagnosis, prediction of stroke severity and outcome, and stratification of patients for stroke therapy. Among the biomarkers discussed are recent whole genome studies using RNA expression profiles to diagnose ischemic stroke and stroke etiology. Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice. With further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with ischemic stroke may be achieved.

Original languageEnglish (US)
Pages (from-to)349-360
Number of pages12
JournalNeurotherapeutics
Volume8
Issue number3
DOIs
StatePublished - Jul 2011

Fingerprint

Biomarkers
Stroke
RNA
Validation Studies
Patient Care
Thrombosis
Ischemia
Genome
Proteins

Keywords

  • Biomarker
  • Ischemic stroke

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Blood Biomarkers of Ischemic Stroke. / Jickling, Glen C.; Sharp, Frank R.

In: Neurotherapeutics, Vol. 8, No. 3, 07.2011, p. 349-360.

Research output: Contribution to journalArticle

Jickling, Glen C. ; Sharp, Frank R. / Blood Biomarkers of Ischemic Stroke. In: Neurotherapeutics. 2011 ; Vol. 8, No. 3. pp. 349-360.
@article{931f60250cce4fcfae89f7fdb216d2ec,
title = "Blood Biomarkers of Ischemic Stroke",
abstract = "This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysiology of ischemic stroke, including ischemia of CNS tissue, acute thrombosis and inflammatory response. These biomarkers are summarized by their intended clinical application in ischemic stroke including diagnosis, prediction of stroke severity and outcome, and stratification of patients for stroke therapy. Among the biomarkers discussed are recent whole genome studies using RNA expression profiles to diagnose ischemic stroke and stroke etiology. Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice. With further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with ischemic stroke may be achieved.",
keywords = "Biomarker, Ischemic stroke",
author = "Jickling, {Glen C.} and Sharp, {Frank R}",
year = "2011",
month = "7",
doi = "10.1007/s13311-011-0050-4",
language = "English (US)",
volume = "8",
pages = "349--360",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Blood Biomarkers of Ischemic Stroke

AU - Jickling, Glen C.

AU - Sharp, Frank R

PY - 2011/7

Y1 - 2011/7

N2 - This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysiology of ischemic stroke, including ischemia of CNS tissue, acute thrombosis and inflammatory response. These biomarkers are summarized by their intended clinical application in ischemic stroke including diagnosis, prediction of stroke severity and outcome, and stratification of patients for stroke therapy. Among the biomarkers discussed are recent whole genome studies using RNA expression profiles to diagnose ischemic stroke and stroke etiology. Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice. With further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with ischemic stroke may be achieved.

AB - This review provides a summary of the protein and RNA biomarkers that have been studied for the diagnosis and assessment of ischemic stroke. Many of the biomarkers identified relate to the pathophysiology of ischemic stroke, including ischemia of CNS tissue, acute thrombosis and inflammatory response. These biomarkers are summarized by their intended clinical application in ischemic stroke including diagnosis, prediction of stroke severity and outcome, and stratification of patients for stroke therapy. Among the biomarkers discussed are recent whole genome studies using RNA expression profiles to diagnose ischemic stroke and stroke etiology. Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice. With further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with ischemic stroke may be achieved.

KW - Biomarker

KW - Ischemic stroke

UR - http://www.scopus.com/inward/record.url?scp=79960829854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960829854&partnerID=8YFLogxK

U2 - 10.1007/s13311-011-0050-4

DO - 10.1007/s13311-011-0050-4

M3 - Article

VL - 8

SP - 349

EP - 360

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 3

ER -